Innate Pharma S.A. Sponsored ADR (IPHA) at a glance

Innate Pharma S.A. Sponsored ADR (IPHA) is a micro-cap Healthcare company. It trades at $2.23, with a 0% profit margin and revenue decline of 46.7%. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Growth (12/100). Its volatility is roughly in line with the market.

Price

$2.23

Market cap

$165.3M

P/E ratio

n/a

Dividend yield

None

Beta

0.89

52-week range

$1.17 to $2.71